# ESMO Interactive Guidelines vs Chronic Lymphocytic Leukemia

The clearest difference is ratings volume: ESMO Interactive Guidelines at 157 against Chronic Lymphocytic Leukemia's 2. ESMO Interactive Guidelines also leads on iOS requirement (12.0 vs 14.0). Chronic Lymphocytic Leukemia's advantage is update cadence (every 2 months vs every 6 months). On price, rating, ads and in-app purchases there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

Chronic Lymphocytic Leukemia holds the better App Store score, 5.0 against 4.8. That said, the two scores are not equally well evidenced: ESMO Interactive Guidelines has 157 ratings behind it against 2, so its average is the more settled of the two.

ESMO Interactive Guidelines ships an update every 6 months, Chronic Lymphocytic Leukemia every 2 months. Both last shipped on October 29, 2026.

## The numbers

| Metric | ESMO Interactive Guidelines | Chronic Lymphocytic Leukemia |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.8 (157 ratings)](https://appshunter.io/ios/app/esmo-interactive-guidelines/id1037353712/reviews) | **[5.0 (2 ratings)](https://appshunter.io/ios/app/chronic-lymphocytic-leukemia/id1058097715/reviews)** |
| Number of ratings | **157** | 2 |
| Positive reviews | 66.7% of reviews | — |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 6 months | **Every 2 months** |
| Monetization | Free | Free |
| Size | 195 MB | 23 MB |
| Requires iOS | **12.0** | 14.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 12+ | 12+ |
| Developer | [European Society for Medical Oncology - ESMO](https://appshunter.io/developer/515544538) | [@Point of Care](https://appshunter.io/developer/916313675) |

## What reviewers say

### ESMO Interactive Guidelines

[App page](https://appshunter.io/ios/app/esmo-interactive-guidelines/id1037353712)

Access concise, practical treatment recommendations based on the latest scientific research. This app provides interactive tools, algorithms, and calculators to support healthcare professionals in decision-making and guideline navigation.

**Highlights:** Concise treatment recommendations, Interactive decision-making tools, Treatment algorithms and calculators, Keyword search functionality, Bookmarking and note-taking, News and push notifications

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### Chronic Lymphocytic Leukemia

[App page](https://appshunter.io/ios/app/chronic-lymphocytic-leukemia/id1058097715)

This clinical decision support tool provides healthcare professionals with evidence-based medical content for managing Chronic Lymphocytic Leukemia. It uses AI to answer natural language questions, offering confidence-rated insights on diagnosis, treatment, and care.

**Highlights:** AI-powered clinical decision support, Evidence-based medical content, Voice-enabled natural language questions, Diagnosis, treatment, and care management topics, Case studies, videos, and interviews, Continuing medical education credit (CME/CE), Patient education resources

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is ESMO Interactive Guidelines free?

ESMO Interactive Guidelines is free to download, with no in-app purchases.

### Is Chronic Lymphocytic Leukemia free?

Chronic Lymphocytic Leukemia is free to download, with no in-app purchases.

### Which has better reviews, ESMO Interactive Guidelines or Chronic Lymphocytic Leukemia?

Chronic Lymphocytic Leukemia is rated higher. ESMO Interactive Guidelines averages 4.8 out of 5 from 157 ratings, while Chronic Lymphocytic Leukemia averages 5.0 from 2 ratings.

### Do ESMO Interactive Guidelines or Chronic Lymphocytic Leukemia have ads?

Neither ESMO Interactive Guidelines nor Chronic Lymphocytic Leukemia shows ads.

### Which is updated more often, ESMO Interactive Guidelines or Chronic Lymphocytic Leukemia?

ESMO Interactive Guidelines ships an update every 6 months, and Chronic Lymphocytic Leukemia every 2 months. Most recently, ESMO Interactive Guidelines was updated on October 29, 2026 and Chronic Lymphocytic Leukemia on October 29, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*